(Q37677553)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

Imaging angiogenesis of genitourinary tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Alan Jackson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Noel Clarke

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gordon C. Jayson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Ying-Kiat Zee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

James P B O'Connor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Andrew R Clamp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M Ben Taylor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

19 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

69-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrurol.2009.262

16 January 2020

exact match

0 references

cites work

Role of angiogenesis in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Prostate cancer: contrast-enhanced us for detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The biology of VEGF and its receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Angiopoietin: a TIE(d) balance in tumor angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The interleukin-8 pathway in cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Sorafenib in advanced clear-cell renal-cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

31 March 2020

12 December 2020

Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Molecular imaging of antiangiogenic agents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

MRI of tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Key factors in the acquisition of contrast kinetic data for oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Imaging microvascular structure with contrast enhanced MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Functional computed tomography in oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Application of CT in the investigation of angiogenesis in oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

PET for in vivo pharmacokinetic and pharmacodynamic measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Measuring tumor blood flow with H(2)(15)O: practical considerations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

31 March 2020

Advances in ultrasound

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Angiogenesis imaging--ultrasound

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

A multivessel model describing replenishment kinetics of ultrasound contrast agent for quantification of tissue perfusion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The pathology of renal epithelial neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The von Hippel-Lindau tumor suppressor gene and kidney cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Percutaneous core biopsy for renal masses: indications, accuracy and results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Renal cancer: preoperative evaluation with dual-phase three-dimensional MR angiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

31 March 2020

Incidental renal tumours

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Small renal masses: the value of contrast-enhanced colour Doppler imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Complex cystic renal masses: characterization with contrast-enhanced US

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Dynamic MRI of small renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Renal masses: quantitative assessment of enhancement with dynamic MR imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Targeted therapy for metastatic renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Differentiation of subtypes of renal cell carcinoma on helical CT scans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

MR classification of renal masses with pathologic correlation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

CT quantification of effects of thalidomide in patients with metastatic renal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Microvessel density in prostate carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The endothelin axis: emerging role in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 tria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Screening and prostate-cancer mortality in a randomized European study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Does sextant prostate biopsy provide adequate sampling for early detection of prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Detection of prostate cancer with a microbubble ultrasound contrast agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Diagnostic usefulness of endorectal magnetic resonance imaging with dynamic contrast-enhancement in patients with localized prostate cancer: mapping studies with biopsy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Angiogenesis imaging in the management of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Pathologic changes associated with androgen deprivation therapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Using Positron Emission Tomography 2-Deoxy-2-[18F]Fluoro-D-Glucose, 11CO, and 15O-Water for Monitoring Androgen Independent Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Natural history of progression after PSA elevation following radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Imaging for recurrent prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Dynamic contrast enhanced MRI in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Detection of bladder tumors with dynamic contrast-enhanced MDCT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Reliability of CT in preoperative evaluation of bladder carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Characterization of image heterogeneity using 2D Minkowski functionals increases the sensitivity of detection of a targeted MRI contrast agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Tracer kinetic model-driven registration for dynamic contrast-enhanced MRI time-series data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Radiation dose reduction without degradation of low-contrast detectability at abdominal multisection CT with a low-tube voltage technique: phantom study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Reduction in dose from CT examinations of liver lesions with a new postprocessing filter: a ROC phantom study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

The role of alpha(v)beta(3) in prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.262

Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer

31 March 2020

1 reference

12 December 2020

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

1 reference

12 December 2020

Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features.

1 reference

12 December 2020

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice

1 reference

12 December 2020

The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy

1 reference

12 December 2020

Monitoring RF ablation.

1 reference

12 December 2020

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration

1 reference

12 December 2020

Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor

1 reference

12 December 2020

Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin

1 reference

12 December 2020

Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue

1 reference

12 December 2020

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography

1 reference

12 December 2020

Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2009.262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20084077%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference